Insufficient scRNA-seq data for expression of GABRQ at single-cell level.
Insufficient scRNA-seq data for expression of GABRQ at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 88% | 935.67 | 2336 / 2642 | 84% | 6.81 | 593 / 705 |
uterus | 48% | 190.44 | 82 / 170 | 59% | 7.50 | 271 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.60 | 1 / 1 |
adrenal gland | 29% | 101.20 | 74 / 258 | 58% | 14.07 | 134 / 230 |
esophagus | 38% | 69.68 | 546 / 1445 | 47% | 2.37 | 86 / 183 |
tonsil | 0% | 0 | 0 / 0 | 84% | 10.70 | 38 / 45 |
prostate | 55% | 108.97 | 134 / 245 | 19% | 0.51 | 96 / 502 |
skin | 28% | 19.99 | 499 / 1809 | 17% | 0.51 | 81 / 472 |
lung | 1% | 0.80 | 3 / 578 | 35% | 2.28 | 401 / 1155 |
kidney | 6% | 3.92 | 5 / 89 | 28% | 1.03 | 254 / 901 |
bladder | 0% | 0 | 0 / 21 | 22% | 2.66 | 112 / 504 |
ovary | 3% | 2.92 | 5 / 180 | 17% | 0.84 | 73 / 430 |
thymus | 6% | 4.23 | 42 / 653 | 8% | 0.41 | 46 / 605 |
breast | 0% | 0.13 | 1 / 459 | 13% | 2.45 | 147 / 1118 |
intestine | 7% | 4.95 | 66 / 966 | 3% | 0.13 | 18 / 527 |
stomach | 0% | 0 | 0 / 359 | 7% | 0.49 | 19 / 286 |
pancreas | 0% | 0 | 0 / 328 | 5% | 0.17 | 9 / 178 |
liver | 1% | 0.51 | 2 / 226 | 3% | 0.08 | 12 / 406 |
peripheral blood | 3% | 4.75 | 32 / 929 | 0% | 0 | 0 / 0 |
adipose | 2% | 1.42 | 25 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.36 | 9 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.15 | 3 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0007165 | Biological process | signal transduction |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0043005 | Cellular component | neuron projection |
GO_0034707 | Cellular component | chloride channel complex |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_1902711 | Cellular component | GABA-A receptor complex |
GO_0004890 | Molecular function | GABA-A receptor activity |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005326 | Molecular function | neurotransmitter transmembrane transporter activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0022851 | Molecular function | GABA-gated chloride ion channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0005254 | Molecular function | chloride channel activity |
Gene name | GABRQ |
Protein name | Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) |
Synonyms | |
Description | FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. |
Accessions | Q9UN88 ENST00000598523.3 |